Three new members have been appointed to the National Advisory Council for Biomedical Imaging and Bioengineering (NACBIB) of the National Institute of Biomedical Imaging and Bioengineering (NIBIB).
The council comprises scientists, engineers, physicians, radiologists, researchers, and other health professionals who represent disciplines in and outside of biomedical imaging and bioengineering. NIBIB, a component of the National Institutes of Health, is dedicated to improving the fundamental understanding, diagnosis, treatment and prevention of disease through biomedical technology research and training.
The NACBIB meets three times per year to advise on policy and program priorities related to the conduct and support of research, training, health information dissemination, and other programs that address biomedical imaging, biomedical engineering, and associated technologies and modalities with biomedical applications. The NACBIB also provides an additional level of review for all applications for funding of research and training grants or cooperative agreements by the NIBIB.
NIBIB Director Roderic I. Pettigrew, Ph.D., M.D., welcomes the following new members:
John C. Gore, Ph.D., is Hertha Ramsey Cress chair in medicine and university professor of radiology and radiological sciences and biomedical engineering, molecular physiology and biophysics, and physics and astronomy, and director of the Institute of Imaging Science, Vanderbilt University Medical Center, Nashville. Dr. Gore is vice-chair for research in the Department of Radiology and Radiological Sciences, as well as an investigator at the Vanderbilt Kennedy Center for Research on Human Development. An international expert in the field of magnetic resonance imaging (MRI) research, Dr. Gore's research program focuses on the development and application of imaging, particularly MRI and spectroscopy techniques, in clinical and basic science; development of methods for studying human brain structure and function using MRI; and use of multimodality imaging to study small animals. Dr. Gore holds multiple patents and has published over 500 peer reviewed journal articles. He is an elected member of the National Academy of Engineering of the National Academies. He is also a fellow of the American Institute for Medical and Biological Engineering, the International Society for Magnetic Resonance in Medicine, and the Institute of Physics (U.K.). Dr. Gore received his Ph.D. in physics from the University of London.
Cato T. Laurencin, M.D., Ph.D. is the director of the Institute for Regenerative Engineering and the chief executive officer of the Connecticut Institute for Clinical and Translational Science, Farmington. He is also the Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery, and professor of chemical, materials and biomolecular engineering at the University of Connecticut, Storrs. An internationally renowned orthopedic surgeon and expert on regenerative tissue, Dr. Laurencin is an elected member of the Institute of Medicine of the National Academies and an elected member of the National Academy of Engineering. His research interests focus on the regeneration of knee and shoulder tissue and limb regeneration. Dr. Laurencin received his M.D. (magna cum laude) from Harvard Medical School, Boston. He is a fellow in the American Academy of Orthopaedic Surgeons, the American College of Surgeons, and the American Surgical Association. Dr. Laurencin received his Ph.D. in biochemical engineering/biotechnology from the Massachusetts Institute of Technology, Cambridge. He is a fellow of the American Institute for Medical and Biological Engineering from which he received the 2009 Pierre Galletti Award, the organization's highest honor. He is also a fellow of the American Institute of Chemical Engineers, which named him one of the 100 Chemical Engineers of the Modern Era at its centennial celebration in 2009.
Mark A. Musen, M.D., Ph.D. is head of the Stanford Center for Biomedical Informatics Research and professor of medicine and computer science at Stanford University, Stanford, Calif. Dr. Musen’s research focuses on intelligent systems; the Semantic Web, a collaborative movement led by the World Wide Web Consortium that promotes common formats for data on the World Wide Web; reusable ontologies, the structural frameworks for organizing information that are used in artificial intelligence and the Semantic Web; knowledge representation; and biomedical decision support. His current work addresses mechanisms by which computers can assist in the development of large, electronic biomedical knowledge bases. His work on the Protégé system, an ontology editor and knowledge-base framework, has led to an open-source technology now used by thousands of developers around the world. Dr. Musen is principal investigator of the National Center for Biomedical Ontology, Stanford, Calif., co-editor-in-chief of Applied Ontology: An International Journal of Ontological Analysis and Conceptual Modeling, and chair of the World Health Organization's Health Informatics and Modeling Topic Advisory Group. He is an elected member of the Association of American Physicians and is a recipient of the Donald A. B. Lindberg award for Innovation in Informatics of the American Medical Informatics Association. Dr. Musen received his Ph.D. in medical information sciences from Stanford University and his M.D. from Brown University, Providence, R.I.
About the National Institute of Biomedical Imaging and Bioengineering (NIBIB): The NIBIB’s mission is to support multidisciplinary research and research training at the crossroads of engineering and the biological and physical sciences. NIBIB supports emerging technology research and development within its internal laboratories and through grants, collaborations, and training. More information is available at the NIBIB website.
About the National Institutes of Health (NIH): The NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. More information is available at the NIH website.
NIH...Turning Discovery Into Health